Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 12, 2025 • 2:00 AM ET

Date/Time Source News Release
04/01/2025 08:00 AM EDT GlobeNewswire Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme
10/23/2023 09:00 AM EDT GlobeNewswire Marizyme CEO Delivers Business Update
10/13/2023 06:00 AM EDT ACCESSWIRE InvestmentPitch Media Video Features Marizyme's CEO David Barthel Discussing Receipt of FDA Clearance for its Flagship DuraGraft Medical Device
10/06/2023 06:34 PM EDT ACCESSWIRE The Watchlist by The Market Herald Releases New Interviews with Marizyme, Regenx, BuildDirect, and Three Sixty Solar Discussing Their Latest News
10/06/2023 09:00 AM EDT GlobeNewswire Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft(TM)
05/10/2023 08:00 AM EDT GlobeNewswire Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products
05/03/2023 08:00 AM EDT GlobeNewswire Marizyme CEO Delivers Business Update
02/25/2022 07:32 AM EST GlobeNewswire Statera Biopharma Announces Changes to Board of Directors
12/23/2021 03:24 PM EST GlobeNewswire Marizyme Announces the Closing of My Health Logic Acquisition Along With Initial Financing
11/16/2021 02:55 PM EST GlobeNewswire Marizyme is Pleased to Announce the Appointment of David Barthel as CEO
Page